Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03829)(COMPLETED)
Launched by ORGANON AND CO · Nov 19, 2008
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
This study is a cross-over study design.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Subjects must be:
- • Between 6 and 11 years of age in good general health
- • Premenarcheal if female
- Exclusion Criteria:
- Subjects who:
- • Have known allergies or sensitivities to either of the drug formulations
- • Have a medical condition that may interfere with the subject's ability to discriminate between tastes
- • Have used any antihistamines within 24 hours prior to dosing
- • Were taking sedatives, tranquilizers, or monoamine oxidase inhibitor drugs
- • Were involved in another clinical or market research study within the past 30 days
About Organon And Co
Organon & Co. is a global healthcare company dedicated to advancing women's health and improving patient outcomes through innovative therapies and solutions. With a strong focus on addressing unmet medical needs, Organon develops and commercializes a diverse portfolio of medicines, including reproductive health, contraception, and other critical areas affecting women's health. Committed to scientific excellence and collaboration, the company engages in clinical trials to explore new treatment avenues and enhance the quality of life for patients worldwide. Through its mission-driven approach, Organon strives to empower women and healthcare providers with the tools and resources necessary for informed decision-making and effective care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials